Results
1 -
10 of
108Ulf-Peter Apfel, Manfred Rudolph, Christina Apfel, Christian Robl, Daniel Langenegger, Daniel Hoyer, Bernhard Jaun, Marc-Olivier Ebert, Theodor Alpermann, Dieter Seebach and Wolfgang Weigand.
Reaction of Fe3(CO)12 with octreotide—chemical, electrochemical and biological investigations with octreotide—chemical, electrochemical and biological investigations, Dalton Trans., 2010, 39, 3065. Flavia Barragán, Virtudes Moreno and Vicente Marchán.
Solid-phase synthesis and DNA binding studies of dichloroplatinum(ii) conjugates of dicarba analogues of octreotide as new anticancer drugs, Chem. Commun., 2009, 4705. Gareth E. Smith, Helen L. Sladen, Stefano C. G. Biagini and Philip J. Blower.
Inorganic approaches for radiolabelling biomolecules with fluorine-18 for imaging with Positron Emission Tomography, Dalton Trans., 2011, 40, 6196. Frank Rösch and Richard P. Baum.
Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS, Dalton Trans., 2011, 40, 6104. Charles R. Robertson, Sean P. Flynn, H. Steve White and Grzegorz Bulaj.
Anticonvulsant neuropeptides as drug leads for neurological diseases, Nat. Prod. Rep., 2011, 28, 741. Xizhe Tian, Kyung-Hwa Baek and Injae Shin.
Dual-targeting delivery system for selective cancer cell death and imaging, Chem. Sci., 2013, 4, 947. Wenjin Xu, Jocelyn F. Burke, Srikanth Pilla, Herbert Chen, Renata Jaskula-Sztul and Shaoqin Gong.
Octreotide-functionalized and resveratrol-loaded unimolecular micelles for targeted neuroendocrine cancer therapy, Nanoscale, 2013, . Tumorwirksame Medikamente, Onkologische Krankenpflege Pharmacokinetic and technical comparison of Sandostatin?? LAR?? and other formulations of long-acting octreotide, BMC Research Notes Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors, World Journal of Surgery